title: [Anabolic therapy of osteoporosis].
abstract: Pharmacological treatment of osteoporosis is based mainly on antiresorptive agents. However, there have been recently developed a group of drugs whose mechanism of action is the direct stimulation of bone formation: these drugs are named bone anabolic therapies. Among these compounds are fluoride, growth hormone (GH), insulin-like growth factor type I (IGF-I) and statins. Two further agents with major evidences of efficacy include strontium ranelate and parathyroid hormone (PTH) and its fragments. The present work reviews the current evidences of anabolic agents used in the treatment of osteoporosis.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario San Cecilio, Granada, Spain.
authors.forename: Diego
authors.initials: D
authors.lastname: Fernández-García
authors.forename: Guillermo
authors.initials: G
authors.lastname: Alonso
authors.forename: Manuel
authors.initials: M
authors.lastname: Muñoz-Torres
mesh_terms: D045930:Anabolic Agents / Q000627:therapeutic use*; D000818:Animals; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D013324:Strontium / Q000627:therapeutic use
chemical_list: D045930:Anabolic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010281:Parathyroid Hormone; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D013324:Strontium